Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future

被引：0
作者：
Plesnila-Frank, C. [1 ]
Rottenkolber, D. [2 ]
Berger, K. [2 ]
机构：
[1] Med Econ Res Grp, Munich, Germany
[2] Univ Hosp Munich, Munich, Germany
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65041-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A283 / A284
页数：2
相关论文
共 50 条
  • [31] Quality of life (QoL) and symptoms in patients with myelodysplastic syndromes (MDS). Investigating the role of transfusion dependency in an International study
    Efficace, Fabio
    Gaidano, Gianluca
    Stauder, Reinhard
    Caocci, Giovanni
    Voso, Maria Teresa
    Bowen, David
    Selleslag, Dominik
    Di Tucci, Anna Angela
    Lunghi, Monica
    Breccia, Massimo
    [J]. QUALITY OF LIFE RESEARCH, 2012, 21 : 8 - 9
  • [32] Clinical Relevance of Individual Response to Iron Chelation Therapy (ICT) in Patients with Myelodysplastic Syndromes (MDS) and Transfusion Requirement
    Latagliata, Roberto
    Niscola, Pasquale
    Oliva, Esther Natalie
    Riva, Marta
    Capodanno, Isabella
    Volpe, Antonio
    Pilo, Federica
    Barate, Claudia
    Campagna, Alessia
    Pelizzari, Anna Maria
    Poloni, Antonella
    Sarlo, Chiara
    Mansueto, Giovanna
    Piccioni, Anna Lina
    Rosati, Serena
    Carmosino, Ida
    Carbone, Antonella
    Tognazzi, Lucia
    Salutari, Prassede
    Mancini, Annalisa
    Cuffari, Patrizia
    Pennese, Elsa
    Fenu, Susanna
    Spiriti, Maria Antonietta Aloe
    Galimberti, Sara
    Molteni, Alfredo
    Balleari, Enrico
    Breccia, Massimo
    Foa, Robin
    Maurillo, Luca
    Finelli, Carlo
    [J]. BLOOD, 2019, 134
  • [33] THE COST OF BLOOD TRANSFUSION IN LOW-RISK PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS): AN ECONOMIC ANALYSIS FOR THE CASE OF GREECE
    Fragoulakis, B.
    Maniadakis, N.
    Panagiotidis, P.
    [J]. HAEMATOLOGICA, 2012, 97 : 145 - 146
  • [34] MYELODYSPLASTIC SYNDROMES (MDS), THEN AND NOW: A COMPARISON OF TWO PATIENT COHORTS, 30 YEARS APART
    Mittelman, M.
    Svorai-Litvak, S.
    Ben-Tal, O.
    Oster, H. S.
    Krigner, I.
    Siegel, R. S.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S154 - S155
  • [35] Challenges in transfusion medicine: Need of transfusion dependent patients with myelodysplastic syndromes
    Plesnila-Frank, C. P.
    Berger, K.
    Voelkl, M.
    Schramm, W.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 313 - 314
  • [36] Model Heterogeneity in Predicting Outcomes of Patients with Myelodysplastic Syndromes (MDS)
    Al-Issa, Karam
    Madanat, Yazan F.
    Mukherjee, Sudipto
    Hirsch, Cassandra M.
    Gerds, Aaron T.
    Abuhadra, Nour
    Makhoul, Ahed
    Awada, Hassan
    Asad, Mohammad Fahad B.
    Goyal, Abhinav
    Advani, Anjali S.
    Kuzmanovic, Teodora
    Przychodzen, Bartlomiej P.
    Carraway, Hetty E.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    Nazha, Aziz
    [J]. BLOOD, 2017, 130
  • [37] Characteristics and Outcome Of Myelodysplastic Syndromes (MDS) Patients With Autoimmune Diseases
    Komrokji, Rami S.
    Kulasekararaj, Austin G.
    Al Ali, Najla H.
    Kordasti, Shahram Y.
    Bart-smith, Emily
    Benjamin, Craig
    Padron, Eric
    Zhang, Ling
    Lancet, Jeffrey E.
    List, Alan
    Mufti, Ghulam J.
    Epling-Burnette, Pearlie K.
    [J]. BLOOD, 2013, 122 (21)
  • [38] Treatment and outcome of 23 paediatric patients with myelodysplastic syndromes (MDS)
    Polychronopoulou, S
    Panagiotou, JP
    Papadakis, V
    Parcharidou, A
    Psiachou, H
    Mavrou, A
    Haidas, S
    [J]. LEUKEMIA, 2000, 14 (05) : 969 - 969
  • [39] Clonal Heterogeneity in Patients with Myelodysplastic Syndromes (MDS) and Complex Karyotypes
    Zemanova, Zuzana
    Michalova, Kyra
    Brezinova, Jana
    Lhotska, Halka
    Svobodova, Karla
    Sarova, Iveta
    Lizcova, Libuse
    Izakova, Silvia
    Ransdorfova, Sarka
    Krejcik, Zdenek
    Belickova, Monika
    Siskova, Magda
    Jonasova, Anna
    Neuwirtova, Radana
    Zmolikova, Jana
    Cermak, Jaroslav
    [J]. BLOOD, 2014, 124 (21)
  • [40] Phase II study of amifostine in patients with myelodysplastic syndromes (MDS).
    List, AF
    Holmes, H
    Greenberg, PL
    Bennett, JM
    Oster, W
    [J]. BLOOD, 1999, 94 (10) : 305A - 305A
12345